Temple is a health-tech startup incubated by Deepinder Goyal that is building a wearable sensor worn on a user’s temples to continuously monitor cerebral blood flow. The device originated from Goyal’s longevity project, Continue, which hypothesises that declining cerebral perfusion—estimated to drop 0.7% per year—contributes to ageing and higher all-cause mortality. By providing high-precision, real-time data that current consumer wearables cannot capture, Temple aims to serve elite athletes first and eventually broaden into wider health and longevity applications. The company claims its sensor suite will deliver novel performance metrics and is actively hiring engineers across analog electronics, embedded systems, sensor algorithms, computational neuroscience, and neuro-imaging machine learning to accelerate product development. More than 30 of its own employees invested personal capital into the company, underscoring internal conviction. Temple has not yet released commercial revenue figures, but the recent financing pegs its valuation at $190 million, giving it a substantial runway for R&D and go-to-market efforts.

Total raised

$54M

Funding rounds

1

Latest round

Seed

Latest activity

Feb 2026